Burburan, Jeric James G.
HRN: 23-06-50 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/18/2023
05/24/2023
IV
173mg
Q24
Pcap C
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes